Skip to main content
Alkem Laboratories Limited logo

Alkem Laboratories Limited — Investor Relations & Filings

Ticker · ALKEM ISIN · INE540L01014 LEI · 335800GCAE5WIF4PSG69 BSE.NS Manufacturing
Open in API
Filings indexed 1,787 across all filing types
Latest filing 2026-05-28 Report Publication Anno…
Country IN India
Listing BSE.NS ALKEM

About Alkem Laboratories Limited

https://www.alkemlabs.com/

Alkem Laboratories Limited specializes in the development, manufacturing, and marketing of pharmaceutical and nutraceutical products. The company’s portfolio covers a wide range of therapeutic areas, including anti-infectives, gastrointestinal, pain management, and vitamins, minerals, and nutrients. It has also expanded into chronic therapeutic segments such as cardiology, diabetology, neurology, and dermatology. Alkem operates multiple manufacturing facilities and advanced research and development centers dedicated to formulation development and active pharmaceutical ingredients. The company provides branded generics, generic medications, and active pharmaceutical ingredients to various international markets. Its operations are supported by a robust supply chain and a focus on high-quality production standards to meet global regulatory requirements.

Recent filings

Filing Released Lang Actions
Record Date
Report Publication Announcement Classification · 88% confidence The document is a brief letter to the stock exchanges under SEBI LODR Regulations announcing the outcome of a Board meeting, stating that the audited standalone and consolidated results and auditor’s report for the quarter and fiscal year ended 31 March 2026 have been approved and are enclosed (and available on the website). It does not itself contain detailed financial data, but merely notifies the publication of those reports. Under the “menu vs meal” rule, this is an announcement that the report is attached/published rather than the report itself. This fits the definition of a Report Publication Announcement (RPA).
2026-05-28 English
The BOD at its meeting held today has recommended a final dividend of Rs. 10 per equity share of Rs. 2 each for FY ended 31st March 26 for approval of the shareholders of the Company at ....
Report Publication Announcement Classification · 82% confidence The document is a short disclosure under India’s SEBI LODR Regulations notifying stock exchanges of the Board meeting outcome. It states that audited results have been approved and are ‘enclosed’ (but does not itself include the full financial statements), along with dividend recommendation, AGM date, record date, and reappointment of a director. It serves to announce the publication and availability of the audited financial results and auditor’s report rather than present substantive financial data. Under the “menu vs. meal” rule for documents under 5,000 characters that refer to attached or published reports, this fits the Report Publication Announcement category (RPA).
2026-05-28 English
Dividend
Report Publication Announcement Classification · 94% confidence The document is an announcement to stock exchanges summarizing the outcome of a board meeting, including approval of audited financial results and enclosing the actual reports, recommendation of dividend, AGM date, record date, and director re-appointment. It does not itself contain detailed financial statements but states that the standalone and consolidated audited results and auditors’ report are attached/available. Under the “menu vs meal” rule, this is a Report Publication Announcement rather than the full report (10-K, IR, etc.).
2026-05-28 English
The BOD at its meeting held today approved the reappointment of Mrs Madhurima Singh as Executive Director for a term of 5 consecutive years wef 20th Dec, 26.
Board/Management Information Classification · 95% confidence The document is a stock exchange disclosure under SEBI Regulation 30 announcing the re-appointment of an Executive Director. It details board-level/management changes, referencing the Nomination and Remuneration Committee recommendation and term of reappointment. This matches the Board/Management Information category.
2026-05-28 English
Pl find enclosed Audited Financial Results along with auditors report for FY ended 31st march 26
Audit Report / Information Classification · 85% confidence The document is the official outcome of the Board meeting held on 28 May 2026, disclosing the Standalone and Consolidated Audited Financial Results for the quarter and financial year ended 31 March 2026 and enclosing the Auditor’s Report thereon. It includes the full independent auditor’s opinion, scope, basis for opinion, and responsibilities – characteristic of a standalone audit report rather than just a brief earnings release or report announcement. It is not a full Annual Report (10-K), nor merely a dividend or management change notice. Therefore, it best fits the “Audit Report / Information” category (AR). FY 2026
2026-05-28 English
Change in Director(s)
Board/Management Information Classification · 97% confidence The document is an official stock exchange disclosure under SEBI LODR Regulations announcing the re-appointment of an Executive Director, including board meeting approval and details of the director’s term. This is a board/management change announcement rather than a full report, vote result, or financial release. Therefore, it falls under Board/Management Information (MANG).
2026-05-28 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.